What genetic mutations are commonly found in Cervical Cancer

Genetic Mutations in Cervical Cancer

I'm glad you're learning about the genetic aspects of cervical cancer. Understanding these mutations helps explain how the disease develops and can guide treatment decisions.

HPV: The Primary Driver

The most important genetic factor in cervical cancer is Human Papillomavirus (HPV) infection, not a mutation you inherit. According to the NCCN Guidelines for Cervical Cancer:

• Over 90% of cervical squamous cell carcinomas (the most common type, accounting for 80-90% of all cervical cancers) are caused by high-risk HPV types, particularly HPV-16 and HPV-18
• HPV is a sexually transmitted infection that most sexually active people encounter at some point
• In most people, the immune system clears the virus naturally
• In others, long-term HPV infection causes persistent cell changes that can develop into cancer over decades

Important distinction: This is an acquired mutation (you get it during your lifetime), not an inherited one you're born with.

HPV-Independent Cervical Cancer (Less Common)

According to NCCN Guidelines, about 5-7% of cervical squamous cell carcinomas are HPV-negative. These tumors typically:

• Occur in older patients (around age 70)
• Present at more advanced stages
• Show different genetic mutations including:
  • TP53 mutations (tumor suppressor gene)
  • KRAS mutations (growth-promoting gene)
  • ARID1A mutations (chromatin remodeling gene)
  • PTEN mutations (tumor suppressor gene)

Testing Recommendations

According to NCCN Guidelines for Cervical Cancer, your pathology report should include:

• HPV testing (using HPV in situ hybridization or molecular testing)
• p16 immunohistochemistry (IHC) - a marker of HPV infection
• For advanced or recurrent disease, comprehensive molecular profiling including:
  • HER2 testing
  • Mismatch repair (MMR)/microsatellite instability (MSI) status
  • Tumor mutational burden (TMB)
  • NTRK gene fusion testing
  • RET gene fusion testing

These additional tests help identify treatment options, especially for recurrent or metastatic disease.

What This Means for You

Questions to ask your healthcare team:

1. What is my HPV status, and what does that mean for my treatment?
2. Have any additional molecular tests been performed on my tumor?
3. If my cancer is HPV-positive, does that change my treatment approach compared to HPV-negative disease?
4. Are there any targeted therapy options based on my tumor's genetic profile?
5. Should I have genetic counseling to discuss inherited cancer risk?

Key Takeaway

Most cervical cancers develop from HPV infection rather than inherited genetic mutations. However, understanding your specific tumor's genetic characteristics—whether it's HPV-positive or has other mutations—helps your oncology team select the most effective treatment approach for your individual case.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.